Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Blumenthal said the ABC structure originated in the 1999 ...

Statins are widely used in the evidence-based lowering of cardiovascular disease (CVD) risk. The use of these drugs for secondary prevention of CVD is well founded, but their expanding use in primary ...

A risk calculator that incorporates established cardiovascular risk factors and additional cardiac biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type ...

The balance of benefits and risks of aspirin in primary prevention is far less clear than in secondary prevention; further data from randomized trials of individuals at intermediate cardiovascular ...

Medscape: Why update the guidelines at this time? Dr. Epstein: At the time when the initial guidelines were written in 1996, the vast majority of ICDs were implanted for secondary prevention in people ...

The Reduction of Atherothrombosis for Continued Health (REACH) registry is a multidisciplinary, multinational registry of more than 45,000 patients with cardiovascular disease or multiple (>3) risk ...

A polypill that includes key medications associated with improved outcomes (aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as a simple approach to the secondary ...

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management ...

Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...